Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2025-522071-28-00Phase 4Authorised
Phase 4, open-label trial of levobupivacaine in labor pain (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Incomplete sensory block at 45 minutes. Planned start Aug 2025; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2025-522071-28-00.